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Conclusion 
The	data	for	the	drug	release	collected	showed	a	
smaller	burst	release	followed	by	a	near	zero-order	
release	for	the	DES,	which	shows	a	constant	rate	of	
drug	release	over	time.	At	2	weeks	after	the	initial	
release,	the	DES	had	40	percent	less	drug	released	
than	PLGA	loaded	with	pure	GEM	precipitates	(p	<	
0.05).	The	measured	sustained	drug	release	will	
eventually	reduce	the	rate	of	restenosis	that	can	be	
induced	by	stents.		
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